December 2020

NEWS & COLUMNS

6-7 NEWS
Sanofi’s quadrivalent flu vaccine
Supemtek scores EU approval; MSD launches antibiotic combo Recarbrio in UK

8-11 CORONAVIRUS NEWS
Pfizer/BioNTech's COVID-19 vaccine approved in UK; WHO director-general says urgent support is needed for COVAX facility

12 DARWIN'S MEDICINE
Chaperone leadership – an insightful parallel between bosses and biology

13 POLICY AND PUBLIC HEALTH
An open letter to the incoming President of the United States on COVID-19 messaging priorities

14 PERFECT PARTNERS
What are the key components for a successful partnership?

15 LAUNCH LEADERS' BLOG
What should launch leaders be measuring?

28-29 RESEARCH NEWS
Life sciences hub set to be
developed in the West Midlands; Life sciences industry in Northern Ireland is ‘flourishing’  

FEATURES

16-17 JANSSEN'S JOAQUÍN
CASARIEGO GARCÍA-LUBÉN
Unlocking the potential of precision medicine in oncology and Janssen's drive to provide personalised cancer care

18-19 CELL AND GENE THERAPY
Thanks to advances in technology and new commercial viability, C&G therapy is finally coming of age

20-21 DATA FROM THE ASCO
QUALITY CARE SYMPOSIUM
The cost-effectiveness of biosimilar treatment options in cancer care

22-23 ADVANCES IN THE
TREATMENT AND PREVENTION
OF CARDIOVASCULAR DISEASE
Cardiovascular outcome trials of omega-3 fatty acids offer hope of an evolution in treatment

26-27 BREXIT: TOO LITTLE, TOO LATE?
What businesses need to know about post-Brexit immigration